These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 35878743)
1. Chimeric Antigen Receptor T Cell Therapy versus Hematopoietic Stem Cell Transplantation: An Evolving Perspective. Goldsmith SR; Ghobadi A; Dipersio JF; Hill B; Shadman M; Jain T Transplant Cell Ther; 2022 Nov; 28(11):727-736. PubMed ID: 35878743 [TBL] [Abstract][Full Text] [Related]
2. Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia. Zhao YL; Liu DY; Sun RJ; Zhang JP; Zhou JR; Wei ZJ; Xiong M; Cao XY; Lu Y; Yang JF; Zhang X; Lu DP; Lu P Front Immunol; 2021; 12():605766. PubMed ID: 34025637 [TBL] [Abstract][Full Text] [Related]
3. Exploring the Dilemma of Allogeneic Hematopoietic Cell Transplantation after Chimeric Antigen Receptor T Cell Therapy: To Transplant or Not? Bouziana S; Bouzianas D Biol Blood Marrow Transplant; 2020 Aug; 26(8):e183-e191. PubMed ID: 32304874 [TBL] [Abstract][Full Text] [Related]
4. Allogeneic Transplantation and Chimeric Antigen Receptor-Engineered T-Cell Therapy for Relapsed or Refractory Mantle Cell Lymphoma. Gauthier J; Maloney DG Hematol Oncol Clin North Am; 2020 Oct; 34(5):957-970. PubMed ID: 32861289 [TBL] [Abstract][Full Text] [Related]
5. How to Combine the Two Landmark Treatment Methods-Allogeneic Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Together to Cure High-Risk B Cell Acute Lymphoblastic Leukemia? Zhang M; Huang H Front Immunol; 2020; 11():611710. PubMed ID: 33384696 [TBL] [Abstract][Full Text] [Related]
6. Is There Still a Role for Transplant for Patients with Mantle Cell Lymphoma (MCL) in the Era of CAR-T Cell Therapy? Beitinjaneh A; Kaufman A; Wang Y; Jain P; Srour SA; Wang M Curr Treat Options Oncol; 2022 Nov; 23(11):1614-1625. PubMed ID: 36227407 [TBL] [Abstract][Full Text] [Related]
7. Safety of allogeneic hematopoietic cell transplant in adults after CD19-targeted CAR T-cell therapy. Shadman M; Gauthier J; Hay KA; Voutsinas JM; Milano F; Li A; Hirayama AV; Sorror ML; Cherian S; Chen X; Cassaday RD; Till BG; Gopal AK; Sandmaier BM; Maloney DG; Turtle CJ Blood Adv; 2019 Oct; 3(20):3062-3069. PubMed ID: 31648329 [TBL] [Abstract][Full Text] [Related]
8. Custom CARs: Leveraging the Adaptability of Allogeneic CAR Therapies to Address Current Challenges in Relapsed/Refractory DLBCL. Jeyakumar N; Smith M Front Immunol; 2022; 13():887866. PubMed ID: 35663947 [TBL] [Abstract][Full Text] [Related]
9. The evolving role of allogeneic haematopoietic cell transplantation in the era of chimaeric antigen receptor T-cell therapy. Dholaria B; Savani BN; Huang XJ; Nagler A; Perales MA; Mohty M Br J Haematol; 2021 Jun; 193(6):1060-1075. PubMed ID: 33928630 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of CD19 CAR-T cell therapy for acute lymphoblastic leukemia patients relapsed after allogeneic hematopoietic stem cell transplantation. Cao XY; Li JJ; Lu PH; Liu KY Int J Hematol; 2022 Sep; 116(3):315-329. PubMed ID: 35737192 [TBL] [Abstract][Full Text] [Related]
12. Use of chimeric antigen receptor T cells in allogeneic hematopoietic stem cell transplantation. Liu J; Zhang X; Zhong JF; Zhang C Immunotherapy; 2019 Jan; 11(1):37-44. PubMed ID: 30702011 [TBL] [Abstract][Full Text] [Related]
13. Humanized Anti-CD19 CAR-T Cell Therapy and Sequential Allogeneic Hematopoietic Stem Cell Transplantation Achieved Long-Term Survival in Refractory and Relapsed B Lymphocytic Leukemia: A Retrospective Study of CAR-T Cell Therapy. Chen W; Ma Y; Shen Z; Chen H; Ma R; Yan D; Shi M; Wang X; Song X; Sun C; Cao J; Cheng H; Zhu F; Sun H; Li D; Li Z; Zheng J; Xu K; Sang W Front Immunol; 2021; 12():755549. PubMed ID: 34777367 [TBL] [Abstract][Full Text] [Related]
14. Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. Pearson AD; Rossig C; Mackall C; Shah NN; Baruchel A; Reaman G; Ricafort R; Heenen D; Bassan A; Berntgen M; Bird N; Bleickardt E; Bouchkouj N; Bross P; Brownstein C; Cohen SB; de Rojas T; Ehrlich L; Fox E; Gottschalk S; Hanssens L; Hawkins DS; Horak ID; Taylor DH; Johnson C; Karres D; Ligas F; Ludwinski D; Mamonkin M; Marshall L; Masouleh BK; Matloub Y; Maude S; McDonough J; Minard-Colin V; Norga K; Nysom K; Pappo A; Pearce L; Pieters R; Pule M; Quintás-Cardama A; Richardson N; Schüßler-Lenz M; Scobie N; Sersch MA; Smith MA; Sterba J; Tasian SK; Weigel B; Weiner SL; Zwaan CM; Lesa G; Vassal G Eur J Cancer; 2022 Jan; 160():112-133. PubMed ID: 34840026 [TBL] [Abstract][Full Text] [Related]
15. ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Multiple Myeloma. Dhakal B; Shah N; Kansagra A; Kumar A; Lonial S; Garfall A; Cowan A; Poudyal BS; Costello C; Gay F; Cook G; Quach H; Einsele H; Schriber J; Hou J; Costa L; Aljurf M; Chaudhry M; Beksac M; Prince M; Mohty M; Janakiram M; Callander N; Biran N; Malhotra P; Otero PR; Moreau P; Abonour R; Iftikhar R; Silberman R; Mailankody S; Gregory T; Lin Y; Carpenter P; Hamadani M; Usmani S; Kumar S Transplant Cell Ther; 2022 Jun; 28(6):284-293. PubMed ID: 35306217 [TBL] [Abstract][Full Text] [Related]
16. Hematopoietic Cell Transplantation and Adoptive Cell Therapy in Peripheral T Cell Lymphoma. Rogers AM; Brammer JE Curr Hematol Malig Rep; 2020 Aug; 15(4):316-332. PubMed ID: 32529515 [TBL] [Abstract][Full Text] [Related]
17. Hematopoeitic Cell Transplantation and CAR T-Cell Therapy: Complements or Competitors? Goldsmith SR; Ghobadi A; DiPersio JF Front Oncol; 2020; 10():608916. PubMed ID: 33415078 [TBL] [Abstract][Full Text] [Related]
18. Allogeneic Hematopoietic Cell Transplantation as Curative Therapy for Patients with Non-Hodgkin Lymphoma: Increasingly Successful Application to Older Patients. Fenske TS; Hamadani M; Cohen JB; Costa LJ; Kahl BS; Evens AM; Hamlin PA; Lazarus HM; Petersdorf E; Bredeson C Biol Blood Marrow Transplant; 2016 Sep; 22(9):1543-1551. PubMed ID: 27131863 [TBL] [Abstract][Full Text] [Related]
19. Case Report: Unedited allogeneic chimeric antigen receptor T cell bridging to conditioning-free hematopoietic stem cell transplantation for a child with refractory Burkitt lymphoma. Yang X; Luo C; Qian J; Huang X; Zhang J; Wang J; Luo C; Qin X; Li B; Chen J Front Immunol; 2023; 14():1219872. PubMed ID: 37736096 [TBL] [Abstract][Full Text] [Related]
20. American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Transplantation Clinical Practice Recommendations for Transplantation and Cellular Therapies in Mantle Cell Lymphoma. Munshi PN; Hamadani M; Kumar A; Dreger P; Friedberg JW; Dreyling M; Kahl B; Jerkeman M; Kharfan-Dabaja MA; Locke FL; Shadman M; Hill BT; Ahmed S; Herrera AF; Sauter CS; Bachanova V; Ghosh N; Lunning M; Kenkre VP; Aljurf M; Wang M; Maddocks KJ; Leonard JP; Kamdar M; Phillips T; Cashen AF; Inwards DJ; Sureda A; Cohen JB; Smith SM; Carlo-Stella C; Savani B; Robinson SP; Fenske TS Transplant Cell Ther; 2021 Sep; 27(9):720-728. PubMed ID: 34452722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]